Andere Kunden interessierten sich auch für
![Leishmaniasis and the role of Iron]( "Leishmaniasis and the role of Iron")
Leishmaniasis and the role of Iron23,99 €![Vaccine Candidates from Fasciola gigantica]( "Vaccine Candidates from Fasciola gigantica")
Vaccine Candidates from Fasciola gigantica40,99 €![Development of a new microparticle vaccine adjuvant, MIS416]( "Development of a new microparticle vaccine adjuvant, MIS416")
Development of a new microparticle vaccine adjuvant, MIS41645,99 €![Expression of Specific Pfemp1 Variants in Severe Childhood Malaria]( "Expression of Specific Pfemp1 Variants in Severe Childhood Malaria")
Expression of Specific Pfemp1 Variants in Severe Childhood Malaria32,99 €![An Overview of Parkinson¿s Disease and its Relevance]( "An Overview of Parkinson¿s Disease and its Relevance")
An Overview of Parkinson¿s Disease and its Relevance19,99 €![Contributions of cellular and humoral immunity]( "Contributions of cellular and humoral immunity")
Contributions of cellular and humoral immunity23,99 €![Vaccinology At A Glance]( "Vaccinology At A Glance")
Vaccinology At A Glance26,99 €
Current treatment against leishmaniasis is solely based on chemotherapy and vaccination remains an alternative for the prevention and control of this dreadful parasitic disease. Extensive proof from animal experimental models indicates that a robust protection can be conferred by immunization with defined subunit vaccines or live-attenuated strains of Leishmania. However, to date, no such vaccine is on hand in spite of substantial efforts. This current study focuses on recent findings in anti-leishmania vaccine field and highlights current difficulties facing vaccine development and its implementation.